These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6098457)

  • 1. Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene.
    Horowitz M; Luria S; Rechavi G; Givol D
    EMBO J; 1984 Dec; 3(12):2937-41. PubMed ID: 6098457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long terminal repeat of the intracisternal A particle as a target for transactivation by oncogene products.
    Luria S; Horowitz M
    J Virol; 1986 Mar; 57(3):998-1003. PubMed ID: 2936901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas.
    Cohen JB; Unger T; Rechavi G; Canaani E; Givol D
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):797-9. PubMed ID: 6656883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome.
    Canaani E; Dreazen O; Klar A; Rechavi G; Ram D; Cohen JB; Givol D
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7118-22. PubMed ID: 6316344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant binding sequence for transcription factor EBP-80 confers increased promoter activity on a retroviral long terminal repeat.
    Falzon M; Kuff EL
    J Biol Chem; 1990 Aug; 265(22):13084-90. PubMed ID: 2165492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse c-mos oncogene activation is prevented by upstream sequences.
    Wood TG; McGeady ML; Baroudy BM; Blair DG; Vande Woude GF
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7817-21. PubMed ID: 6096859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the long terminal repeats of intracisternal A-particle genes: sequences within the U3 region determine both the efficiency and direction of promoter activity.
    Christy RJ; Huang RC
    Mol Cell Biol; 1988 Mar; 8(3):1093-102. PubMed ID: 2452971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long terminal repeat of an endogenous intracisternal A-particle gene functions as a promoter when introduced into eucaryotic cells by transfection.
    Lueders KK; Fewell JW; Kuff EL; Koch T
    Mol Cell Biol; 1984 Oct; 4(10):2128-35. PubMed ID: 6095042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene.
    Kuff EL; Feenstra A; Lueders K; Rechavi G; Givol D; Canaani E
    Nature; 1983 Apr; 302(5908):547-8. PubMed ID: 6835385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro methylation inhibits the promotor activity of a cloned intracisternal A-particle LTR.
    Feenstra A; Fewell J; Lueders K; Kuff E
    Nucleic Acids Res; 1986 May; 14(10):4343-52. PubMed ID: 2423967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transposon-like repeat interrupted by an LTR element occurs in a cluster of B1 repeats in the mouse c-mos locus.
    Propst F; Vande Woude GF
    Nucleic Acids Res; 1984 Nov; 12(22):8381-92. PubMed ID: 6095198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of oncogenes by transposable elements.
    Givol D
    Biochem Soc Symp; 1986; 51():183-96. PubMed ID: 3028423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse intracisternal A particle-promoted placental gene retrotransposition is mouse-strain-specific.
    Chang-Yeh A; Mold DE; Brilliant MH; Huang RC
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):292-6. PubMed ID: 7678343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An abundant placental transcript containing an IAP-LTR is allelic to mouse pregnancy-specific glycoprotein 23 (Psg23): cloning and genetic analysis.
    Ball M; McLellan A; Collins B; Coadwell J; Stewart F; Moore T
    Gene; 2004 Jan; 325():103-13. PubMed ID: 14697515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences in the long terminal repeats of the Moloney murine sarcoma virus-124 genome which control transforming gene function.
    Narayanan R; Srinivasan A; Aaronson SA
    Virology; 1984 Aug; 137(1):32-40. PubMed ID: 6089418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras oncogene activates the intracisternal A particle long terminal repeat promoter through a c-AMP response element.
    Galien R; Mercier G; Garcette M; Emanoil-Ravier R
    Oncogene; 1991 May; 6(5):849-55. PubMed ID: 1828874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative and positive effects of an IAP-LTR on nearby Pcdaalpha gene expression in the central nervous system and neuroblastoma cell lines.
    Sugino H; Toyama T; Taguchi Y; Esumi S; Miyazaki M; Yagi T
    Gene; 2004 Aug; 337():91-103. PubMed ID: 15276205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site.
    Pal SK; Zinkel SS; Kiessling AA; Cooper GM
    Mol Cell Biol; 1991 Oct; 11(10):5190-6. PubMed ID: 1833632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
    Gorman CM; Merlino GT; Willingham MC; Pastan I; Howard BH
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6777-81. PubMed ID: 6294651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.